Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
7.85M
-
Shares change
-
-208K
-
Total reported value, excl. options
-
$29.5M
-
Value change
-
-$830K
-
Number of buys
-
10
-
Number of sells
-
-13
-
Price
-
$3.76
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2018
34 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q4 2018.
scPharmaceuticals Inc. - Common Stock (SCPH) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.85M shares
of 53.4M outstanding shares and own 14.7% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.41M shares), RA CAPITAL MANAGEMENT, LLC (2.86M shares), AWM Investment Company, Inc. (414K shares), BlackRock Inc. (358K shares), Alyeska Investment Group, L.P. (177K shares), Vanguard Group Inc (161K shares), STATE STREET CORP (112K shares), NORTHERN TRUST CORP (68.9K shares), GEODE CAPITAL MANAGEMENT, LLC (51.9K shares), and Parametric Portfolio Associates LLC (39.8K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.